Triple

T37697518
Position Surface form Disambiguated ID Type / Status
Subject Gaviscon E938969 entity
Predicate instanceOf P0 FINISHED
Object antacid medication C65217 CONCEPT FINISHED

How this triple was built (1 step)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

CD Concept disambiguation gpt-5-mini-2025-08-07
Target class: antacid medication
Context triple: [Gaviscon, instanceOf, antacid medication]
  • A. antacid chosen
    An antacid is a substance, typically an over-the-counter medication, that neutralizes excess stomach acid to relieve symptoms like heartburn, indigestion, and acid reflux.
  • B. histamine H2 receptor antagonist
    A histamine H2 receptor antagonist is a drug that selectively blocks histamine H2 receptors on gastric parietal cells, thereby reducing stomach acid secretion and helping to treat conditions like peptic ulcers and gastroesophageal reflux disease.
  • C. antidiarrheal drug
    An antidiarrheal drug is a medication used to reduce the frequency and urgency of bowel movements and alleviate symptoms associated with diarrhea.
  • D. medication
    A medication is a substance or combination of substances administered to diagnose, treat, prevent, or alleviate symptoms of disease or medical conditions in humans or animals.
  • E. antidote
    An antidote is a substance or treatment that counteracts or neutralizes the effects of a poison, toxin, or harmful agent in a living organism.
  • F. None of above.

Provenance (1 batch)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69f76eda6ae48190b3111071eeacc038 completed May 3, 2026, 3:50 p.m.
Created at: May 3, 2026, 4:18 p.m.